Longitudinal assessment of cardiac function in infants with Down's syndrome using novel echocardiography techniques -

Aisling Smith1, Eleanor Molloy2,3, Jan Miletin3

  • 1Department of Neonatology, The Rotunda Hospital, Dublin, Dublin, D01P5W9, Ireland.

HRB Open Research
|June 7, 2021
PubMed

Insights

This study investigates cardiac function in infants with Down syndrome (DS), focusing on pulmonary hypertension (PH) and congenital heart disease (CHD). Findings will improve monitoring and outcomes for DS patients with cardiovascular conditions.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Down syndrome (DS) is the most common global chromosomal abnormality, with Ireland reporting a high incidence (1:444 live births).
  • Congenital heart disease (CHD) and pulmonary hypertension (PH) are prevalent cardiovascular comorbidities in DS, significantly increasing morbidity and mortality risks.
  • The impact of DS, CHD, and PH on myocardial function during transition and early childhood remains poorly understood, necessitating further investigation.

Purpose of the Study:

  • To characterize myocardial function and pulmonary hemodynamics in infants with Down syndrome.
  • To assess these parameters during the transitional period (first week of life) and up to two years of age.
  • To compare findings in infants with DS to a control group of healthy infants.

Main Methods:

  • A prospective, observational study design.
  • Utilizing novel echocardiography techniques to evaluate myocardial function and pulmonary hemodynamics.
  • Recruiting infants with Down syndrome and a control group of healthy infants across three Dublin maternity units.

Main Results:

  • 70 babies with DS enrolled, with 292 echocardiograms performed to date.
  • Ongoing data collection to further evaluate cardiac performance in DS infants.
  • Analysis will focus on insights into the pathophysiology of cardiac dysfunction and PH in this population.

Conclusions:

  • Further evaluation of cardiac performance in DS infants with and without CHD is crucial.
  • This research may enhance understanding of cardiac dysfunction and pulmonary hypertension pathophysiology.
  • Findings could improve patient monitoring, treatment strategies, and outcome prediction for individuals with Down syndrome and cardiovascular conditions.